Brain microglia in psychiatric disorders

Valeria Mondelli1, Anthony C Vernon2, Federico Turkheimer3

  • 1Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK; National Institute for Health Research Mental Health Biomedical Research Centre, South London and Maudsley NHS Foundation Trust and King's College London, London, UK.

The Lancet. Psychiatry
|April 30, 2017
PubMed

Insights

Immune activation, particularly involving microglia (brain macrophages), is studied in psychiatric disorders. Findings suggest neuroinflammation isn't universal in patients and may link to psychosocial stress, impacting future treatments.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Immunology

Background:

  • Immune activation's role in psychiatric disorders is a growing research area.
  • Microglia, the brain's resident immune cells, are central to this investigation.

Purpose of the Study:

  • To review current literature on microglia activation in various psychiatric disorders.
  • To explore the link between psychosocial stress and neuroinflammation in psychiatric conditions.

Main Methods:

  • Comprehensive literature assessment of human post-mortem and in-vivo studies.
  • Analysis of experimental animal studies on microglia activation.

Main Results:

  • Microglia activation is observed across psychiatric disorders, but not consistently in all patients.
  • No clear association found between microglia activation and specific diagnostic categories.
  • Psychosocial stress identified as a significant factor influencing microglial activation.

Conclusions:

  • The precise cause and implications of neuroinflammation in psychiatric disorders remain unclear.
  • Findings suggest potential therapeutic targets related to psychosocial stress and microglial function.

Related Concept Videos